Hemme, E., Depuydt, M. A., van Santbrink, P. J., Wezel, A., Smeets, H. J., Foks, A. C., . . . Bot, I. (2024). Leukemia inhibitory factor receptor inhibition by EC359 reduces atherosclerotic stenosis grade in Ldlr−/− mice. European journal of pharmacology, 985, 177121. https://doi.org/10.1016/j.ejphar.2024.177121
Chicago-Zitierstil (17. Ausg.)Hemme, Esmeralda, Marie A.C Depuydt, Peter J. van Santbrink, Anouk Wezel, Harm J. Smeets, Amanda C. Foks, Johan Kuiper, und Ilze Bot. "Leukemia Inhibitory Factor Receptor Inhibition by EC359 Reduces Atherosclerotic Stenosis Grade in Ldlr−/− Mice." European Journal of Pharmacology 985 (2024): 177121. https://doi.org/10.1016/j.ejphar.2024.177121.
MLA-Zitierstil (9. Ausg.)Hemme, Esmeralda, et al. "Leukemia Inhibitory Factor Receptor Inhibition by EC359 Reduces Atherosclerotic Stenosis Grade in Ldlr−/− Mice." European Journal of Pharmacology, vol. 985, 2024, p. 177121, https://doi.org/10.1016/j.ejphar.2024.177121.